Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II

Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II

In about 70% of cases, ovarian carcinoma has been diagnosed at an advanced stage. Invasion and metastasis of solid tumors request protease activity resulting in basal membrane destruction and surrounding matrix. In that process, urokinase plasminogen activator (uPA) and its receptor, urokinase plas...

Full description

Bibliographic Details
Main Authors: Dženita Ljuca, Zlatan Fatušić, Ermina Iljazović, Begzudin Ahmetović
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2007-05-01
Series:Biomolecules & Biomedicine
Subjects:
ovarian carcinoma
chemotherapy
urokinase plasminogen activator-uPA
urokinase plasmino-gen activator receptor-suPAR
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/3063

Internet

https://www.bjbms.org/ojs/index.php/bjbms/article/view/3063

Similar Items